» Articles » PMID: 33019628

Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers

Abstract

Although antibody response to SARS-CoV-2 can be detected early during the infection, several outstanding questions remain to be addressed regarding the magnitude and persistence of antibody titer against different viral proteins and their correlation with the strength of the immune response. An ELISA assay has been developed by expressing and purifying the recombinant SARS-CoV-2 Spike Receptor Binding Domain (RBD), Soluble Ectodomain (Spike), and full length Nucleocapsid protein (N). Sera from healthcare workers affected by non-severe COVID-19 were longitudinally collected over four weeks, and compared to sera from patients hospitalized in Intensive Care Units (ICU) and SARS-CoV-2-negative subjects for the presence of IgM, IgG and IgA antibodies as well as soluble pro-inflammatory mediators in the sera. Non-hospitalized subjects showed lower antibody titers and blood pro-inflammatory cytokine profiles as compared to patients in Intensive Care Units (ICU), irrespective of the antibodies tested. Noteworthy, in non-severe COVID-19 infections, antibody titers against RBD and Spike, but not against the N protein, as well as pro-inflammatory cytokines decreased within a month after viral clearance. Thus, rapid decline in antibody titers and in pro-inflammatory cytokines may be a common feature of non-severe SARS-CoV-2 infection, suggesting that antibody-mediated protection against re-infection with SARS-CoV-2 is of short duration. These results suggest caution in using serological testing to estimate the prevalence of SARS-CoV-2 infection in the general population.

Citing Articles

Longitudinal determination of seroprevalence and immune response to SARS-CoV-2 in a population of food and retail workers through decentralized testing and transformation of ELISA datasets.

Djaileb A, Parker M, Lavallee E, Stuible M, Durocher Y, Theriault M PLoS One. 2024; 19(12):e0314499.

PMID: 39680559 PMC: 11649073. DOI: 10.1371/journal.pone.0314499.


Transient Expression in HEK-293 Cells in Suspension Culture as a Rapid and Powerful Tool: SARS-CoV-2 N and Chimeric SARS-CoV-2N-CD154 Proteins as a Case Study.

Lao T, Farnos O, Bueno A, Alvarez A, Rodriguez E, Palacios J Biomedicines. 2023; 11(11).

PMID: 38002050 PMC: 10669214. DOI: 10.3390/biomedicines11113050.


Unveiling a New Perspective on Distinguishing Omicron Breakthrough Cases and Postimmune COVID-19-Naive Individuals: Insights from Antibody Profiles.

Zhang S, Dong C, Zhen Q, Shi C, Tian H, Li C Microbiol Spectr. 2023; 11(4):e0180823.

PMID: 37432106 PMC: 10433813. DOI: 10.1128/spectrum.01808-23.


Waning anti-SARS-CoV-2 receptor-binding domain total antibody in CoronaVac-vaccinated individuals in Indonesia.

Harapan H, Ar Royan H, Tyas I, Nadira A, Abdi I, Anwar S F1000Res. 2023; 11:300.

PMID: 37260419 PMC: 10209622. DOI: 10.12688/f1000research.109676.2.


The importance of combining serological testing with RT-PCR assays for efficient detection of COVID-19 and higher diagnostic accuracy.

Alamri S, Alsaieedi A, Khouqeer Y, Afeef M, Alharbi S, Algaissi A PeerJ. 2023; 11:e15024.

PMID: 37065688 PMC: 10103696. DOI: 10.7717/peerj.15024.


References
1.
DAlessandro M, Bennett D, Montagnani F, Cameli P, Perrone A, Bergantini L . Peripheral lymphocyte subset monitoring in COVID-19 Italian patients. Minerva Med. 2020; 112(3):423-426. DOI: 10.23736/S0026-4806.20.06638-0. View

2.
Gudbjartsson D, Norddahl G, Melsted P, Gunnarsdottir K, Holm H, Eythorsson E . Humoral Immune Response to SARS-CoV-2 in Iceland. N Engl J Med. 2020; 383(18):1724-1734. PMC: 7494247. DOI: 10.1056/NEJMoa2026116. View

3.
Edridge A, Kaczorowska J, Hoste A, Bakker M, Klein M, Loens K . Seasonal coronavirus protective immunity is short-lasting. Nat Med. 2020; 26(11):1691-1693. DOI: 10.1038/s41591-020-1083-1. View

4.
Gong J, Dong H, Xia Q, Huang Z, Wang D, Zhao Y . Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study. BMC Infect Dis. 2020; 20(1):963. PMC: 7750784. DOI: 10.1186/s12879-020-05681-5. View

5.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View